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Quality control (QC) of medical imaging devices is essential to ensure their proper function
and to gain accurate and quantitative results. Therefore, several international bodies have
published QC guidelines and recommendations for a wide range of imaging modalities to
ensure adequate performance of the systems. Hybrid imaging systems such as positron
emission tomography/computed tomography (PET/CT) or PET/magnetic resonance
imaging (PET/MRI), in particular, present additional challenges caused by differences
between the combined modalities. However, despite the increasing use of this hybrid
imaging modality in recent years, there are no dedicated QC recommendations for
PET/MRI. Therefore, this work aims at collecting information on QC procedures across
a European PET/MRI network, presenting quality assurance procedures implemented
by PET/MRI vendors and achieving a consensus on PET/MRI QC procedures across
imaging centers. Users of PET/MRI systems at partner sites involved in the HYBRID
consortium were surveyed about local frequencies of QC procedures for PET/MRI.
Although all sites indicated that they perform vendor-specific daily QC procedures,
significant variations across the centers were observed for other QC tests and testing
frequencies. Likewise, variations in available recommendations and guidelines and the
QC procedures implemented by vendors were found. Based on the available information
and our clinical expertise within this consortium, we were able to propose a minimum
set of PET/MRI QC recommendations including the daily QC, cross-calibration tests,
and an image quality (IQ) assessment for PET and coil checks and MR image quality
tests for MRI. Together with regular checks of the PET–MRI alignment, proper PET/MRI
performance can be ensured.
Keywords: hybrid imaging, consensus, recommendations, quality control, PET/MRI
Valladares et al. Consensus on PET/MRI QC
INTRODUCTION
With the introduction of clinical PET/MRI systems in 2010 [1, 2],
a novel hybrid PET system became available, in addition to
PET/CT and SPECT/CT. The combination of PET with MRI
has several advantages; it offers high soft tissue contrast by MRI,
together with a reduced radiation burden compared to CT [3].
Moreover, the high-resolution anatomical images from MRI can
be used for accurate partial volume correction (PVC) [4] and
fast MRI sequences can be used to correct for motion in PET
examinations [5]. Further, a broad spectrum of available MRI
sequences offers a variety ofmulti-parametric information, which
bears high potential to improve disease characterization through
radiomics and machine learning (ML) approaches [6].
Nonetheless, the typically rather low number of available
datasets for a specific disease from PET/MRI in a single-center
renders a systematic evaluation of possible advantages over other
modalities, and the use of PET/MRI data for ML approaches
challenging. Therefore, pooling of PET/MRI data across multiple
imaging centers is desirable.
However, comparability of imaging data from hybrid PET
information is often hampered by differences in local imaging
protocols and quality control standards [7–9]. In addition to
variations in imaging protocols driven by local preferences of
the physicians in charge, variations in QC procedures and
imaging protocols, as demonstrated for PET/CT operations
[7], can be widely attributed to differences in system design
between vendors and system generations (mainly using different
reconstruction algorithms or settings). However, in contrast to
PET/CT, there are only three main PET/MRI systems on the
market all introduced between 2010 and 2015. Thus, all systems
have implemented state-of-the-art reconstruction algorithms as
well as similar technological characteristics. Therefore, a smaller
variation in QC procedures and IQ parameters of PET/MRI
compared with PET/CT could be expected. However, first
findings indicate that this is not the case. Boellaard et al. [10]
reported high accuracy of phantom-basedQC for three PET/MRI
systems, but only when using dedicated phantom acquisition and
processing protocols; when using clinical protocols, significant
variances between the systems were reported. Further, in a
previous multi-center trial, the inter-site variability of NEMA
image quality evaluations was reported to be similar to
previous reports for PET/CT systems [11]. These findings are
an indication that similar variabilities in PET/MRI operation,
including basic quality control standards, exist as it was shown
for PET/CT.
Currently, there are several recommendations on quality
assurance procedures for PET, PET/CT, and MRI systems
[12–16] and guidelines for standardized imaging protocols
[12, 13, 15, 17, 18]. For PET/MRI, one report exists describing
the implementation of a simultaneous hybrid PET/MRI
system in an integrated research and clinical setting [19].
Further, two guidelines for oncological whole-body [18F]-FDG-
PET/MRI [20, 21] have been published. However, there is
currently no recommendation dedicated to QC procedures for
PET/MRI systems.
This work aims at (a) summarizing relevant guidelines
and recommendations by international bodies on PET and
MRI quality control programs, (b) assessing variations of
local QC procedures at European hybrid imaging sites, (c)
summarizing PET/MRI QC procedures implemented by system’s
manufacturers, and (d) developing a consensus recommendation
of a minimal set of QC measures for PET/MRI throughout the
HYBRID (Healthcare Yearns for Bright Researchers for Imaging
Data) consortium.
MATERIALS AND METHODS
HYBRID is an innovative training network project funded by
the European Commission (MSCA No. 764458). It aims at
promoting the field of non-invasive disease characterization in
the light of personalized medicine by enhancing the information
gained from molecular and hybrid imaging technologies. The
HYBRID consortium brings together international academic,
industrial and non-governmental partners in a cross-specialty
network including eight partner sites with extensive clinical
experience in PET/MRI as well as three vendors of currently
available PET/MRI systems.
Summary of Existing Recommendations
To get an overview of the existing and recommended
QC tests for PET and MRI systems, we summarized QC
guidelines and recommendations published by all major
international bodies related to the field of medical imaging.
For PET and PET/CT these included suggestions by the
American College of Radiology (ACR) [17], the Society of
Nuclear Medicine and Molecular Imaging (SNMMI), and the
European Association of Nuclear Medicine (EANM) through
the EANM Research Ltd (EARL) initiative [15, 22], the
International Atomic Energy Agency (IAEA) [16] and the
Intersocietal Accreditation Commission (IAC) [23]. For MRI,
we gathered information from the ACR [13] and the IAC
[14]. All the information was grouped in a table to have a
complete overview of the differences and similarities between
different recommendations.
State of Implementation of QC Procedures
Based on international QC guidelines and recommendations,
we designed a survey to collect information about the QC tests
and testing frequencies from all eight users of PET/MRI systems
within the HYBRID consortium.
The survey form itself contained two tables: one with the
list of the QC tests for the PET part of the systems, and the
second one with commonly used MRI QC tests. For each test,
the eight participating sites were asked to report the testing
frequency at which they perform these tests. Further, the form
permitted the addition of information regarding phantoms and
tools used or any other free-text comments regarding the
implemented procedures.
To increase the response rate from the participants, the
document included an introduction to the topic, the aim of
the survey and contact details for support during the time of
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evaluation. All documents, including the survey form, were sent
by email to the imaging centers during summer-autumn 2018.
Responses were grouped by PET/MRI system (one per center)
in a single table and served as the basis for a consensus on
PET/MRI QC.
QC Procedures Implemented by the Vendor
As supporting data for discussions on routine PET/MRI QC
procedures, the quality control procedures implemented in three
available PET/MRI systems (the Siemens Biograph mMR [2], the
GE SIGNA PET/MR [24], and the Ingenuity TF PET/MR [1])
were summarized. These included daily quality assurance (DQA)
procedures and additional regular tests. The information was
collected from the user manuals of the systems and information
provided directly by the vendors.
Consensus Recommendation on QC for
PET/MR
Based on the available recommendations for stand-alone
PET(/CT) and MRI systems, the responses to the survey on
QC procedures and the vendor’s implemented quality assurance
measures, recommendations for PET/MRI QC were drafted.
Findings were presented to and discussed with the participants of
the survey, which included experienced clinical PET/MRI users,
to achieve a consensus on a minimum set of PET/MRI QC
procedures from the HYBRID consortium.
RESULTS
Existing Recommendations for PET and
MRI Modalities
Recommended QC tests and testing frequencies for PET(/CT)
andMRI reported by international organizations are summarized
in Tables 1, 2, respectively. For PET, all guidelines included
the Daily QC (as implemented by the vendor) and a test for
image uniformity. However, other suggested tests and testing
frequencies differ between the guidelines. For example, for
the sensitivity, spatial resolution, and image uniformity a high
variability of testing frequencies, tools, and calculation methods
was observed. Likewise, for MRI systems, the testing frequencies
for most of the tests such as image uniformity, linearity, spatial
resolution, table positioning, slice thickness, and slice positioning
were highly variable.
State of Implementation of QC Procedures
All of the eight participating centers completed the form for
the available PET/MRI systems on-site resulting in reported QC
procedures for five Siemens Biograph mMR PET/MR, two GE
SIGNA PET/MR, and one Philips Ingenuity TF PET/MR. Of
note, the GE and Philips systems have PET time-of-flight (TOF)
capabilities. Survey forms were mainly completed by the on-site
medical physics expert.
The DQA protocol provided by the vendors was
indicated to be performed daily for all systems. However,
the testing frequencies of other evaluated tests were highly
variable (Table 3).
Tests and Testing Frequencies for the PET
Component
DQA procedure
All PET/MRI centers indicated that they perform the DQA as
implemented by the manufacturers, including the assessment
of detector stability. It is performed automatically or semi-
automatically with phantoms provided by vendors, after the
routine system initialization or start-up. One of the GE sites
(center 7) indicated they perform a daily check of the PET
system readiness monitor and an additional monthly DQA,
including a partial detector set-up with coincidence timing
calibration (CTC).
Timing resolution
At 3/8 of the centers (two Siemens and one Philips), the test was
indicated to be performed daily. Variations across the answers
for other Siemens systems ranged from performing the test “by
manufacturer’s recommendations” to “not performed as part of
the routine QC.” Responses for the GE systems varied between
monthly and quarterly.
Sensitivity
The testing frequency for this test presented a high variability
across the centers. The answers were: daily, quarterly, annually,
or at the commissioning of the system (during the acceptance
test). One of the Siemens centers indicated not performing the
test as part of the routine QC.
Spatial resolution
Two of the involved centers did not present any specific testing
frequency for this test, Center 4 indicated to perform it daily, and
the rest of the answers (62.5 % of the systems) ranged from yearly
to once every 10 years.
Image uniformity
Three of the eight centers indicated a daily testing frequency;
another three indicated they perform the test every 3months, one
center reported the test to be done annually, and one reported not
to perform it as part of the routine QC.
Normalization
A daily testing frequency was reported for 4 Siemens PET/MRI
systems. From three of the sites (GE and Philips systems), the test
was indicated to be done every 3 months. Only one of the centers
indicated to perform the normalization test every 6 months.
Image quality and attenuation accuracy. Scatter correction
and quantitation
Three centers indicated to performing the test annually, one
of them specified to use the NEMA IQ phantom. One center
reported to perform it every 10 years, two at the acceptance
testing and one reported not to perform it as part of the
routine QC.
Tests and Testing Frequencies for the MRI
Component
Responses on the QC tests and testing frequencies for the MRI
component varied significantly across partner sites. A summary
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Daily Daily Daily Daily
Detector stability N/A Daily or when available N/A Daily
Coincidence timing resolution N/A N/A N/A Daily for TOF PETs
Clinical mode acquisition N/A N/A N/A Daily (optional procedure)
Sensitivity Annually Daily or when available N/A Whenever performance
change is suspected
Spatial resolution Quarterly N/A N/A Quarterly or when available






























or after a hardware
change
Quarterly
Image quality and accuracy of
attenuation, and scatter correction
and quantitation
Annually Annually





Preventive maintenance N/A By manufacturer’s
recommendation
As well as calibration of




PET and CT images alignment check




N/A Quarterly and after gantries
are separated
CT Part
CT laser alignment Monthly and after laser’s
serviceb
Tabletop alignment and positional
accuracy, and scout scan accuracy
Monthly
also, after serviceb
CT number and uniformity, image
noise and artifacts
Monthlyc
High contrast spatial resolution (MTF
or modulation)













or after service that can
affect MTF
Scatter radiation and shielding
verification according to local
regulations
Annually
KVp-values and HVL to verify
appropriated filtration between source
and patient
Annually
also, after major changes
Dosimetry Annually
Electron density accuracy N/A N/A N/A Annuallyd
Recommended QC tests and testing frequencies by international guidelines. N/A, the test is not included in the guideline, or testing frequency is not specified.
aWhen performing normalization monthly, it is recommended to perform a detector calibration every 3 months or prior to the normalization if there are noticeable changes in QC over
the preceding month.
b If the PET/CT system is used for radiotherapy planning, the test should be performed daily or prior to the patient examination.
cDaily, Water CT number; monthly, CT number of other materials.
dThe test applied only if the PET/CT system is used for radiotherapy planning.
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Resonance/center frequency Weekly Dailya




Linearity (geometry accuracy) Weekly Acceptance testing
High-contrast spatial resolution Weekly Acceptance testing
Low-contrast spatial resolution Weekly Acceptance testing




Table positioning Weekly N/A
Slice thickness accuracy Quarterly Acceptance testing
Slice position/separation error (also
called slice position accuracy)
Quarterly Acceptance testing
Radiofrequency coil checks Annually Annually
Preventive maintenance Annually Annually
This table summarizes the recommendations on QC for MRI systems given by international
guidelines. All the tests should be included in the acceptance testing to establish
references values for the routine QC results. In this table, N/A: the test or testing frequency
is not specified in the guideline.
aDepending on the stability of the system, the test can be performed weekly instead daily.
of all the results of the QC survey can be found in Table 3.
Results can be summarized in two statements: (I) there are no
standard QC procedures for MRI or (II) the QC procedures are
done entirely by and with phantoms provided by the vendors.
We obtained a different response, only for some specific tests.
The resonance frequency test for one of Siemens Biograph mMR
(center 3) is indicated to be performed daily. For the Philips
Ingenuity TF PET/MR, four of the surveyed tests [resonance
frequency, image uniformity, linearity, and radiofrequency (RF)
coils check tests] are performed weekly.
Additional to the performance tests for the PET and the
MRI component of the system, PET and MR images alignment
was reported to be checked with varying frequencies between
centers with answers ranging from: at acceptance test or after an
engineering service and by manufacturer’s recommendation to
regular checks in intervals between 3 and 12 months.
The frequency of the preventive maintenance was reported to
be every 3 months in most of the centers with just two centers
indicating intervals of every 6 months and yearly.
QC Procedures Implemented by the Vendor
Tables 4–6 present tests and testing frequencies included in the
DQA of the Siemens, GE and Philips PET/MRI systems. A
detector stability test is included within all DQA procedures.
However, other tests vary between vendors. For the PET
component of GE and Siemens systems, the DQA by the vendors
is based on a 68Ge/68Ga PET Annulus Phantom (a hollow
cylinder with a thick radioactive wall) and a cylindrical 68Ge/68Ga
phantom, respectively. The DQA by Siemens includes testing
the correct function of the detectors and electric components
of the system. It includes an assessment of block noise, block
efficiency, system efficiency, and image plane efficiency. Further,
it includes a measurement of randoms and scatter ratio, a
normalization check, an inspection of the sinograms, and it
performs a partial detector setup. For the GE PET/MRI systems,
the DQA includes an assessment of the collected coincidences
and singles, an assessment of deadtime, energy peak, and gain
changes. In contrast, the DQA of the Philips systems is based
on a 22Na point source. The DQA include the inspection of
the sinograms and an assessment of the energy resolution. For
SIGNA GE PET/MR and Philips Ingenuity TF PET/MR, systems
with TOF capabilities, the DQA by vendors also includes a timing
resolution check.
Differences across the QC protocols implemented by the
vendor were found for the MRI part of the PET/MRI systems.
Within the Siemens DQA, a coil check is available. Further,
the preventive maintenance usually includes an image quality test
using the head and body spherical phantoms (180 and 300mm
outer diameter, respectively) provided by the vendor. This test
allows an assessment of signal-to-noise ratio (SNR) and artifacts.
Also, procedures to check each configured local coil individually
based on evaluation of SNR and image intensity are available and
done usually during preventive maintenance to verify satisfactory
coil operation.
For GE systems, at least one specific phantom is provided to
check the MRI component; the TLT spherical phantom is used
to test geometry accuracy, ghosting level, and SNR. The test is
available in the DQA implemented by the vendor, but the system’s
user can decide to perform it or not.
For Philips systems, the DQA does not include any test
for the MRI component. However, Philips provides a 200mm
head phantom to check the MRI component of the Ingenuity
TF PET/MRI through an MRI IQ evaluation. This procedure
is recommended to be done weekly and can be performed
automatically by the system. However, it is recommended to
visually check the images for artifacts (e.g., ghosting and lines).
Consensus Recommendation on QC for
PET/MRI
The minimum consensus on PET/MRI QC includes for all the
systems the following tests: For the PET component, the DQA
implemented by the vendor, a quarterly cross-calibration (CC)
test and a yearly IQ test. For the MRI component, the consensus
includes a monthly coil check and an MR image quality test to be
performed at least quarterly. Further, the check of the PET-MRI
alignment should be performed after mechanical manipulations
on the PET/MRI gantry and after software updates. Table 7
summarizes the proposed recommendations, including the
purpose of the test, testing frequency, and additional comments
for the implementation on three of the commercially available
PET/MRI systems.
DISCUSSION
In this work, existing QC guidelines for PET and MRI systems
were summarized, and the variability of implemented QC
protocols for PET/MRI systems was assessed with the ultimate





























TABLE 3 | Performed QC tests and testing frequencies for PET/MRI systems across the participant sites.
Test Siemens GE Philips
CENTER 1 CENTER 2 CENTER 3 CENTER 4 CENTER 5 CENTER 6 CENTER 7 CENTER 8
PET Part

































Sensitivity Daily N/P At acceptance test.
Measurement of the absolute
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Daily,
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decides automatically if the test
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TABLE 3 | Continued
Test Siemens GE Philips
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TABLE 4 | DQA tests for Siemens Biograph mMR PET/MR systems.
Imaging
component
Test Tool/calculation Tolerance criteria
PET Partial detector setup PET 20 cm mMR 68Ge Daily QC phantom (uniform) and the required holder
Parts of the PET detector electronics are calibrated during this test.
Not apply
Normalization PET 20 cm mMR 68-Ge Daily QC phantom (uniform) and the required holder
New normalization map is created. Further, it checks if a valid and successful
normalization result is available in the system’s database. Sinograms of the phantom
scan are displayed, and visual assessment is required.
Normal looking sinogram is
expected.
Block noise The system displays the number of blocks out of range. 0–3 crystals
Block efficiency Checks for a uniform detector response by comparing a block response to the
average of all the block responses. The system displays the number of blocks out of
range.
80–120%
Measured randoms Checks the capability of the system for measuring random events. 85–115%
Scanner efficiency Checks the counting rate produced by a known activity concentration. 33.6–62.4
(count/sec)/(Bq/cc)
Scatter ratio Checks the scatter fraction by a known activity concentration 31.5–38.5%
Scanner efficiency
correction factor (ECF)
Calculates the value of the scanner quantification factor to determine the ratio
between the activity in the scanner and the detected counts.
1.8E007–2.8E007
(Bq*s)/(ECAT counts)
Image plane efficiency To determine hardware variances of line of response detection to getting a uniform
image. The system displays the number of planes out of range.
0–5%
The daily procedure included by the vendor only checks the PET component of the PET/MRI systems. It aims to perform a PET setup and normalization. The reference values for these
tests are established during acceptance testing and updated to the last calibration of the system. The boundaries shown in the table serve only as an example. No MRI-related tests
are included in the DQA. The MRI component is checked during preventive maintenance/service. Ref: Biograph mMR. Function Description. System. Tune-Up/QA. © Siemens, 2011.
goal to reach a consensus on a minimum set of QC procedures.
The results revealed quite significant variations between the
existing recommendations and QC measures implemented in
different centers. The reported variations of local PET and MRI
QC procedures and testing frequencies are assumed to partly
reflect the variations seen in the existing guidelines for the single
modalities and the non-existence of specific recommendations
for PET/MRI. However, in part, the variability in the reporting
seems to be caused by differences in the definition of the specific
tests between the centers and a lack of in-depth knowledge about
the implemented QCmeasures included in the DQA and the tests
performed by the vendor during the preventive maintenance. For
example, the sensitivity of a PET system reflects howmany events
can be detected for a given activity within the field of view (FOV).
A change in sensitivity can possibly be caused by malfunctioning
detectors, changes in the energy resolution or the coincidence
timing window. The NEMA NU2 protocols give clear testing
procedures [26] to measure sensitivity in a reproducible and
standardized way. However, to monitor sensitivity and to assess
potential changes, multiple methods can be used. For example,
the sensitivity can be monitored using the long half-life sources
used for DQA (e.g., 68Ga/68Ge). Therefore, these differences in
methods to measure sensitivity can lead to differences in local
definitions of this test, and thus, to differences in implementation
and reporting. It can be seen in the results from the survey,
where the answers indicate that some of the centers seem
to refer to the specific NEMA NU2 protocol as the test for
sensitivity, and thus, report this test to be done only during
acceptance testing.
QC, as part of a quality assurance program, aims atmonitoring
if a system works as expected. For proper performance of the
PET part, the detectors and measurement electronics need to
work correctly. Checking the detector stability and sensitivity
allows early detection of any sudden changes (e.g., failures
of detector modules). Normalization is needed to correct for
variations of the efficiency of individual detectors and is essential
for uniformity in reconstructed PET images. Further, the spatial
resolution of a PET system, mainly dependent on the detector
geometry and the set reconstruction protocol, is relevant for
lesion detectability and quantitative readings of small structures.
In TOF PET systems, the measurement of the timing resolution
is needed to ensure TOF precision. Furthermore, the cross-
calibration of the PET with the dose calibrators needs to be
ensured for accurate quantitative measurements like SUVs. With
the proposed recommendation, including the DQA, a quarterly
cross-calibration test, and a yearly IQ assessment, proper PET
performance can be ensured.
The DQA provided by the vendors covers most of the tests
mentioned before. For all systems, the correct functionality
of the detectors is checked, and the stability of sensitivity is
assessed by the counts collected from a known activity source
(68Ge/68Ga cylinder phantom for Siemens, 68Ge/68Ga PET
Annulus Phantom for GE and 22Na point source for Philips).
Further, for systems with TOF capabilities, a timing resolution
test is included in the DQA, and for the Siemens PET/MRI
system, the normalization map of the detectors is renewed. All
these parameters are evaluated within the DQA compared to
a baseline established at the commission of the system and
updated during the last calibration or after replacement of the
DQA source.
In addition to the DQA, cross-calibration is required to
ensure proper quantification. The CC test is done using a
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TABLE 5 | DQA tests for GE SIGNA PET/MR systems.
Imaging
component
Test Tool/calculation Tolerance criteria
PET Coincidence PET annulus phantom
Number of coincidence events associated with each crystal element.
Coincidence counts or prompt rates with the DQA phantom are assessed by
measuring the system mean, and the per block (4 × 9 crystals) mean against the
expected values from a decay-corrected baseline. This test assesses system
ability to produce coincidence events from detected singles and their timing
values.
Coincidence directly relates to sensitivity during patient acquisitions.
System mean change < ±9% of
baseline
Block mean change < ±18%
of baseline
Singles PET annulus phantom
Number of individual events detected in each crystal. Singles counts or singles
rates with the DQA phantom are assessed by measuring the system mean, and
the per block (4 × 9 crystals) mean against the expected value from a baseline
after compensating for phantom activity decay. This test assesses system ability
to detect and acquire singles events.
System mean change < ±9% of
baseline
Block mean change < ±27%
of baseline
Deadtime PET annulus phantom
The fraction of time that each detector block is busy. A high value may indicate
noisy electronics or a light leak in the detector. A zero value indicates a loss of
signal which should match low values in singles and coincidence.
System mean change ±0.002
Block change ±0.003
Timing PET annulus phantom
Coincide timing error for each crystal. Timing measurements indicate how many
fractional bins of timing adjustment would be needed to calibrate timing. Timing
bin size is 13.02 ps.
−1 to +1
System mean change < ±0.1 bins, <
±1.3 ps
Block mean change < ±5 bins, <
±65 ps
Energy peak PET annulus phantom
Peak energy spectrum of all crystals. Changes in position of the Energy Peak
indicate that the current measured energy values, not including real-time gain
stabilization (RTGS), have changed from their calibrated target positions. This
can occur under conditions of thermal changes in the detection system and
indicate a need to calibrate the gain.
System mean change < ±8%
Gain changes PET annulus phantom
Gain assessment indicates the percentage change in gain that would be needed
to adjust measured energies to their target values. Assessment is performed on
each of 18 gain channels per detector block and on the mean value of change
for the entire block.
Block mean change < ±6%




Calculation of the relative diameter of the phantom along the phase and
frequency directions x, y, and z (e.g., Dx = Dphase, x - Dfreq, x). Here, D is the
ratio between the measured and known diameter of the phantom along x, y,
and z-direction.
Not applicable
Ghosting level TLT spherical phantom.
Average value of the signal reported in a square 25 pixel ROI (5 × 5 pixels) in the




Ratio S/N calculated from one signal image and one noise image. Calculation of
transmit gain (TG in 0.1 dB) and center frequency (CF in Hz). This test can be
performed with different combinations of coil/phantoms/holders
Not applicable
The results obtained from the PET component are compared with a baseline established at the commissioning of the system and updated quarterly. Ref: SIGNATM PET/MR. 26.0
Operator Manual English 5770625-1EN (2017/11) Rev.2. ©General Electric Company, 2017.
homogeneously water filled cylinder usually provided by the
vendor together with the respective attenuation correction
protocol. A change in cross-calibration is unlikely to be caused
by a change in PET system stability [27]. Therefore, changes are
expected to be mostly related to replacement of the 68Ge/68Ga
phantom (for GE and Siemens DQA) which are also used
for PET calibration, changes in the calibration of the dose
calibrators or modified cross-calibration factors after software
updates. To covering all these potential influencing factors, an at
least quarterly cross-calibration check for 18F is recommended.
Furthermore, CC checks and eventually CC adjustments have to
be performed after replacements of the DQA phantoms, software
updates or changes in the dose calibrators used for patient
injection dose measurements. In addition to the CC, the CC
phantom measurements can be used for the evaluation of the
axial and transaxial uniformity, e.g., using the method published
by the IAEA [16], and it is used for the normalization of the
Philips PET/MRI system.
Frontiers in Physics | www.frontiersin.org 9 September 2019 | Volume 7 | Article 136
Valladares et al. Consensus on PET/MRI QC
TABLE 6 | DQA tests for Philips Ingenuity TF PET/MR systems.
Imaging
component
Test Tool/calculation Tolerance criteria
PET System initialization Restarts the hardware and firmware on the system If the system initialization fails, the program
stops
Hardware sensor test Verifies that voltages and currents are correct for PET gantry electronics Not specified
Baseline collection The system collects the analog offsets of all photomultiplier channels
as baseline data. These baseline values are used by the scanner
processing electronics as a reference in each data collection and after
baseline collection.
The system displays a message indicating
when a Baseline Collection is completed
successfully.
If the measured values are slightly outside the
normal range, it is possible using the scanner.
If the measured values are significantly outside
the allowed range, the scanner should not
be used.
PMT gain calibration Optimizes the electronic gain for each PMT channel. When the system
cannot calibrate all the PMTs for the target gain value within the allowed
number of tries, the system displays a failed status message.
Target gain value
Energy 22Na source centered in a 256mm FOV.
Collects list View data and calculates the energy centroids and FWHM.
Energy centroids should be ∼100.
FWHM Threshold.
Timing 22Na source centered in a 256mm FOV.
The Timing Test compares the system timing against the
calibration settings.
Reference values from timing calibration.
Emission sinogram 22Na source centered in a 256mm FOV.
Collects data for the emission QC sinogram for 2min. Alerts when the
system drift affects image quality or if acquisition hardware is defective.
Visual assessment
Summary of the test, tools, and calculation methods for the daily QC of the PET component of the system. Also, a weekly test using a 200mm head phantom is suggested for the IQ
test of the MRI component. Ref, Information provided by the vendor.
In general, a PET system uses a single CC factor usually based
on 18F. In theory, this should allow a correct quantification of
any PET isotope, given the correct set of correction factors for
differences in positron branching ratios and half-life in the PET
software and, in case of non-pure positron emitters, a proper
prompt gamma correction [28]. However, previous studies have
reported deviations in CC for isotopes other than 18F [29].
These deviations were attributed to incorrect calibration factors
within the dose calibrators [30] or effects resulting from the use
of different isotope containers between calibration and clinical
routine [31]. To account for these issues, a check of the CC for
all PET isotopes in clinical use is recommended to be done at
least once. In case of deviations in CC for additional isotopes, it is
recommended to adjust the dose calibrator settings accordingly.
In cases where this is not possible (e.g., due to legal restrictions
concerning the calibration of the dose calibrator) the deviation
in quantification needs to be communicated with the respective
personal and has to be taken into account if quantitative readings
are used for comparison between different PET systems. Further,
as a regular QC it is recommended to check the dose calibrator
settings for all used isotopes at least yearly (e.g., following a
procedure as described in Logan et al. [32]) and, in case of doubt,
perform an additional CC test.
With the DQA and the cross-calibration measurements,
the proper function of the PET system is essentially ensured.
However, in compliance with the EARL initiative, a yearly IQ
test is recommended additionally to get an assessment of the
overall system performance regarding image quality and, as
contrast recovery- and recovery coefficients are dependent on the
spatial resolution, also spatial resolution. To do so, a protocol
as described by NEMA NU2 [33] or the EARL accreditation
program [34] can be used. Further, the IQ phantom acquisition
can be used to assess uniformity evaluating standard deviation
and mean values of background regions-of-interest [35]. In case
the NEMA IQ phantom is not available on-site, the alternative
use of the ACR PET Phantom can be considered to assess overall
image quality. Procedures for the measurements and image
analysis of the ACR PET Phantom are described in Difilippo
et al. [36], American College of Radiology [37], American College
of Radiology [38]. However, corresponding valid attenuation
correction maps are required when using PET phantoms for
QC of PET/MRI systems [10, 39, 40]. Therefore, when adopting
the ACR Phantom for IQ assessments, dedicated protocols (e.g.,
using CT-based templates for AC) must be available.
On top of the tests mentioned above, the synchronization of
the clocks of all relevant devices (e.g., PET/MRI, dose calibrator,
well-counter) needs to be ensured for accurate quantitative PET
readings [41].
For the MRI component of the PET/MRI systems, we
recommend doing at least an evaluation of the image quality
by means of SNR, geometric accuracy, and artifacts (e.g.,
ghosting, lines). With an overall IQ test, which includes the
parameters mentioned, distortions in resonance frequency, static
B0 field, and gradient field can also be detected. For example,
magnetic field homogeneity has a direct impact on the SNR.
Therefore, GE has an implemented DQA for MRI including
IQ assessment, Philips recommends an IQ assessment to be
done weekly and Siemens systems allow general performance
of the MRI component to be tested by using the head and
body spherical phantoms, and thus, IQ assessment through
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TABLE 7 | HYBRID consensus recommendations on quality control tests for PET/MRI systems.
Imaging
component
Test Purpose Frequency Siemens GE Philips
PET Daily QC To check the proper
operation of the PET
detectors, check system
response to a given activity
source and determine the
correct initialization and
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alignment
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co-registration of the PET






Always after separation of the gantries or other major




Summary of the recommended test, the purpose of the test, testing frequencies. Specific information for the Biograph mMR PET/MR, the GE SIGNA PET/MR, and the Ingenuity TF
PET/MR is also included.
artifacts and SNR calculation in the phantom images is
feasible. In general, we suggest performing the MR image
quality test by using the procedure and phantoms specified
by the vendor. If no specifications are provided, the MRI
IQ can be tested as described by the AAPM and ACR [42,
43]. The ACR suggests performing an MRI IQ test annually.
However, the possibility to discover fails (e.g., in image
intensity uniformity) with a higher testing frequency has been
demonstrated [44]. Therefore, we suggest performing an MRI IQ
test quarterly.
It is also recommended to check the function and quality of
additional hardware such as coils. Checking the coil performance
permits the detection of issues with the coils before these affect
clinical scans and clinical image quality. This test is particularly
important when using flexible coils, which are more susceptible
to deterioration. The procedure for coil performance testing
may be provided by coil or MRI system manufacturer, but can
also be done by analyzing the image SNR and artifacts for
specific phantom-coil arrangements, as described in American
College of Radiology [43]. International guidelines for dedicated
MRI systems suggest to perform an annual coil check; however,
PET/MRI systems vendors such as Siemens suggest a daily test
of the primary coils in use. Therefore, for easy implementation,
we suggest performing a monthly coil check of the most used
coils on-site, and whenever new/replacement coils need to
be accepted.
Finally, no significant interference between the PET and
MRI components has been observed for combined clinical
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3T PET/MRI systems [2, 45–47], and therefore, QC test
performed simultaneously on PET and MRI might not be
required. However, the spatial alignment of both components
needs to be ensured. Checking the image co-registration for
different sequences used clinically may help to reduce the effect
of misalignment artifacts, such as incorrect interpretation of
fused images due to improperly localized lesions in oncological
PET/MRI studies [48]. The test should always be performed after
separation of the gantries and software updating since the offset
calibration values can be overwritten.
Considerations for Specific Applications
It should be mentioned that the QC for MRI covers only
a basic evaluation of the most critical parameters for proper
performance of the imaging modality. Therefore, specific
MRI techniques and sequences may require higher standards
concerning the stability of specific parameters. For example,
MRI applications such as ultrafast imaging (echo-planar imaging,
EPI) will be more sensitive to field inhomogeneities and thus,
may require more stringent testing [49]. Inhomogeneities in B0
magnetic field produce blurring, distortion, and signal loss at
tissue interfaces, particularly at the edge of the field of view.
These image distortions are relevant as they may cause errors
in tissue segmentation on anatomical images and attenuation
correction [50]. Likewise, distortions in the image scale
(geometry) may cause significant bias in radiotherapy planning
[51]. Therefore, it is recommended to include additional QC
procedures tailored to the specific purpose and depending on the
MRI application.
As an example, one of the centers involved in this consensus
has created three specific QC procedures to monitor the MRI
scanner’s behavior for specific applications frequently performed
on-site. MR spectroscopy QC is performed every week. The
procedure entails a single voxel acquisition on the manufacturer-
provided spectroscopy phantom containing water, acetone, and
lactate. The water and acetone peaks are monitored for peak-
frequency, peak-SNR, and peak-width. Furthermore, an MRI
diffusion QC is performed weekly. In this case, the acquisition
of apparent diffusion coefficient maps (ADC) and fractional
anisotropy (FA) in themanufacturer-provided dopedwater bottle
phantom is performed. Average ADC and FA within the bottle
are monitored. A monthly QC procedure was implemented to
monitor potential RF artifacts created by a blood-sampling pump
which operates within the scanner room. The pump is switched
on while a manufacturer-created RF noise scan performed. The
peaks created by the pump are monitored for location and
SNR, to intervene if the peak amplitude or position shifts away
from normal.
CONCLUSION
Existing QC guidelines and recommendations for PET and MR
imaging modalities vary both, in detail and range. Likewise,
variations in local PET/MRI QC measures across European
hybrid imaging sites were reported. However, these variations
can partly be attributed to differences in the definitions of the
tests and a lack of in-depth knowledge of the tests performed
during DQA.
Based on these observations, a recommendation for a
minimum set of QC procedures was developed in consensus, to
ensure the proper functioning of whole-body PET/MRI systems.
This recommendation includes the DQA, a cross-calibration
measurement and an assessment of IQ for PET, a regular IQ test
for MRI as well as a regular coil check, and checks of the PET and
MRI alignment.
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